Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.
Metastasis is an inefficient process; only a few cancer cells are able to form tumors after being released into the circulation. We studied the fate of cancer cells after injection into the circulation, quantifying their survival and ability to extravasate by 1 day later. B16F10 cells, parental or transfectants overexpressing tissue inhibitor of metalloproteinases 1, were injected i.v. into chorioallantoic membrane of chick embryos and analyzed by intravital videomicroscopy. Cell survival was quantified in two ways: (a) 15-microns microspheres were injected with cancer cells, and proportions of viable cells to microspheres were compared before and after injection; and (b) individual cancer cells were monitored continuously for 0.5-8-h intervals covering the first 24 h. Both methods showed virtually no destruction of cells. Greater than 80% of injected cells survived and extravasated by 24 h, indicating that growth after extravasation is a key stage of metastatic control.
Koop
S
S
Department of Medical Biophysics, University of Western Ontario, London, Canada.
MacDonald
I C
IC
Luzzi
K
K
Schmidt
E E
EE
Morris
V L
VL
Grattan
M
M
Khokha
R
R
Chambers
A F
AF
Groom
A C
AC
D000482:Allantois / Q000098:blood supply; D000818:Animals; D002455:Cell Division; D002470:Cell Survival; D002642:Chick Embryo; D002823:Chorion / Q000098:blood supply; D006023:Glycoproteins / Q000032:analysis / Q000096:biosynthesis; D008222:Lymphokines / Q000096:biosynthesis; D008546:Melanoma, Experimental / Q000473:pathology*; D051379:Mice; D008833:Microcirculation / Q000502:physiology*; D009362:Neoplasm Metastasis / Q000473:pathology*; D011994:Recombinant Proteins / Q000032:analysis / Q000096:biosynthesis; D013997:Time Factors; D019714:Tissue Inhibitor of Metalloproteinases; D014162:Transfection
D006023:Glycoproteins; D008222:Lymphokines; D011994:Recombinant Proteins; D019714:Tissue Inhibitor of Metalloproteinases